The Legal and Regulatory Status of Biosimilars: How Product Naming and State Substitution Laws May Impact the United States Healthcare System. [electronic resource]
- American journal of law & medicine 2015
- 49-84 p. digital
Publication Type: Journal Article
0098-8588
10.1177/0098858815591509 doi
Biosimilar Pharmaceuticals Drug Labeling--legislation & jurisprudence Drug Substitution Drugs, Generic Humans United States